BNP/CALL/MERCK & CO./85/0.1/19.12.25 Share Price

Warrant

DE000PC1LLF9

Market Closed - Börse Stuttgart 12:42:51 05/07/2024 pm IST
4.13 EUR -0.72% Intraday chart for BNP/CALL/MERCK & CO./85/0.1/19.12.25
Current month-10.41%
1 month-5.92%
Date Price Change
05/24/05 4.13 -0.72%
04/24/04 4.16 -6.09%
03/24/03 4.43 +2.07%
02/24/02 4.34 +6.63%
01/24/01 4.07 -11.71%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 12:42 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1LLF
ISINDE000PC1LLF9
Date issued 11/12/2023
Strike 85 $
Maturity 19/12/2025 (530 Days)
Parity 10 : 1
Emission price 2.35
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.86
Lowest since issue 2.36
Spread 0.02
Spread %0.48%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus